Slovakia vs Uruguay: Cause of death, by non-communicable diseases, ages 5-14
Slovakia
58.1%
in 2021
Uruguay
57.6%
in 2021
Slovakia rank
36th
Uruguay rank
39th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Slovakia
- Uruguay
How they compare
Slovakia currently reports 58.1% against 57.6% in Uruguay, a difference of 0.5%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Slovakia ahead.
Slovakia ranks 36th and Uruguay ranks 39th of 185 countries.
Across the 3 decades both report, Slovakia averaged higher in 2 and Uruguay in 1.
Head to head by decade
| Decade | Slovakia | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.9% | 46.9% | 3.0% | Slovakia |
| 2010s | 58.3% | 56.6% | 1.7% | Slovakia |
| 2020s | 56.1% | 59.4% | 3.3% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Slovakia or Uruguay?
- Slovakia, at 58.1% against 57.6% in Uruguay as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Slovakia and Uruguay?
- 0.5%, with Slovakia ahead.
- How many years of comparable data are there for Slovakia and Uruguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Slovakia and Uruguay rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Slovakia ranks 36th and Uruguay ranks 39th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.